SPECTRUM AND SEVERITY OF ADVERSE DRUG REACTIONS DURING TREATMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS. (2026). International Research Journal of Pharmacy, 17(9), 11-17. https://doi.org/10.56802/cyzkpf46